RLMD · Relmada Therapeutics, Inc. · Debt
$3.77
+0.04 (+1.07%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$408.55M
Shares
106.67M
Volume · Sep 30
999.53K
Avg daily vol (3M)
1.36M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.